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generation sequencing, may possibly change this and contribute
to a differential diagnosis in the future.
Easy diagnosis of BA has been on the agenda for decades. But,
despite all efforts, as long as we still do not understand the
aetiology and triggering factors of BA we remain at risk of
missing the correct diagnosis for a child with NC just based on
non-invasive diagnostics.
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To the Editor:
We read with great interest the paper by El-Guindi et al. [1],
evaluating a new diagnostic score for biliary atresia (BA). BA
is a destructive inﬂammatory obliterative cholangiopathy of
unknown origin that affects intra- and extrahepatic bile ducts.
Success of surgical correction, in form of a Kasai portoenterosto-
my amongst other factors, depends on early diagnosis and timely
intervention. Presently, there are no non-invasive diagnostic
methods that can clearly identify infants with BA from other
causes of neonatal cholestasis (NC). The current paradigm to
exclude BA in any cholestatic infant hence requires evidence to
prove patency of the extrahepatic bile duct [2–5]. To date, many
research groups have tried to improve the differential diagnosis
[6] but none has yet reached sensitivity and speciﬁcity as high
as in the present study. We are convinced that elements of the
proposed scoring may help in the pre-selection of infants to
undergo imaging of the extrahepatic bile duct. However we are
concerned that the study cohort of patients investigated might
be skewed, thus limiting the diagnostic power of this score.
(1) Entry criteria did not describe if there were children with
drug- or total parenteral nutrition-associated cholestasis
or premature infants in the study population.
(2) There was no information whether there were children
with the syndromic form of BA, with biliary stones,
dilatation of bile ducts or choledochal cysts in the study
cohort.
(3) Important and common causes of NC, such as alpha-1
antitrypsin deﬁciency, cystic ﬁbrosis, bile acid synthetic
disorders, tyrosinemia type 1, galactosemia and hypopitu-
itarism were not identiﬁed.
(4) Normal or low values of gamma-glutamyl transpeptidase
(GGT) in a child with NC imply a defect of bile excretion
at the canalicular level. So it was not surprising that in
the group of non-BA patients the level of GGT was lower
than in the BA group. There was no information about
the type of the progressive familial intrahepatic cholestasis
(PFIC I or II) and whether the multi-drug resistance protein
3 (MDR3) was examined.
A variety of diseases can exactly mimic all separate features of
BA and only systematic evaluation of the entire spectrum will
lead to a reliable diagnosis. Only innovative tools, such as nextReply to: ‘‘A diagnostic score for biliary atresia’’
or:
iate the interest of Pﬁster et al. in our recent study [1]
like to comment on the issues raised in their letter.
Although the concerns that were raised by Pﬁster et al. are
interesting, none is related to the applicability of the BA score
as the recruitment in our study was consecutive for all cases
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